TREM2 modulators
TW202626652APending Publication Date: 2026-07-01MUNA THERAPEUTICS APS
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114143406
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-02-07
- Filing Date
- 2025-11-07
- Publication Date
- 2026-07-01
Abstract
The present invention relates to compounds useful for modulating Triggering Receptor Expressed on Myeloid Cells-2 (“TREM2”). The invention also relates to the compounds for use in treatment of conditions related to loss of function of TREM2, such as neurodegenerative diseases, and to pharmaceutical compositions comprising the compounds.
Need to check novelty before this filing date? Find Prior Art